See more : Sodexo S.A. (SDXOF) Income Statement Analysis – Financial Results
Complete financial analysis of Envista Holdings Corp (NVST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Envista Holdings Corp, a leading company in the Medical – Equipment & Services industry within the Healthcare sector.
- Medhelp Care Aktiebolag (publ) (MEDHLP.ST) Income Statement Analysis – Financial Results
- HOYA Resort Hotel Group (2736.TWO) Income Statement Analysis – Financial Results
- Pucara Gold Ltd. (PCRAF) Income Statement Analysis – Financial Results
- GetFugu, Inc. (GFGU) Income Statement Analysis – Financial Results
- Tandy Leather Factory, Inc. (TLF) Income Statement Analysis – Financial Results
Envista Holdings Corp (NVST)
About Envista Holdings Corp
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.57B | 2.57B | 2.51B | 2.28B | 2.75B | 2.84B | 2.81B | 2.79B |
| Cost of Revenue | 1.12B | 1.09B | 1.08B | 1.12B | 1.24B | 1.24B | 1.19B | 1.18B |
| Gross Profit | 1.45B | 1.47B | 1.43B | 1.16B | 1.51B | 1.60B | 1.62B | 1.60B |
| Gross Profit Ratio | 56.52% | 57.41% | 56.86% | 50.75% | 54.99% | 56.31% | 57.68% | 57.48% |
| Research & Development | 93.80M | 100.10M | 100.50M | 100.80M | 154.70M | 172.00M | 172.40M | 142.80M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.06B | 1.06B | 1.02B | 1.02B | 1.08B | 1.13B | 1.06B | 1.06B |
| Other Expenses | 268.30M | 3.10M | 2.40M | -900.00K | 1.50M | 2.70M | 100.00K | -1.10M |
| Operating Expenses | 1.42B | 1.16B | 1.12B | 1.12B | 1.24B | 1.30B | 1.23B | 1.20B |
| Cost & Expenses | 2.54B | 2.25B | 2.20B | 2.25B | 2.47B | 2.55B | 2.42B | 2.38B |
| Interest Income | 0.00 | 38.40M | 54.10M | 62.50M | 3.50M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 63.40M | 38.40M | 54.10M | 62.50M | 3.50M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 162.60M | 162.10M | 151.90M | 163.10M | 168.10M | 130.00M | 121.40M | 127.20M |
| EBITDA | 171.10M | 484.40M | 460.50M | 205.60M | 447.10M | 454.80M | 508.10M | 530.00M |
| EBITDA Ratio | 6.67% | 18.85% | 18.35% | 8.57% | 10.14% | 15.06% | 18.08% | 19.03% |
| Operating Income | 31.50M | 319.20M | 306.20M | 33.30M | 110.90M | 298.40M | 386.60M | 402.80M |
| Operating Income Ratio | 1.23% | 12.42% | 12.20% | 1.46% | 4.03% | 10.49% | 13.75% | 14.46% |
| Total Other Income/Expenses | -86.40M | -35.30M | -51.70M | -63.50M | 39.80M | 2.70M | 100.00K | -1.10M |
| Income Before Tax | -54.90M | 283.90M | 254.50M | -30.10M | 275.50M | 301.10M | 386.70M | 401.70M |
| Income Before Tax Ratio | -2.14% | 11.05% | 10.14% | -1.32% | 10.01% | 10.59% | 13.76% | 14.42% |
| Income Tax Expense | 45.30M | 45.90M | -9.00M | -63.40M | 57.90M | 70.40M | 85.60M | 129.70M |
| Net Income | -100.20M | 243.10M | 263.50M | 33.30M | 217.60M | 230.70M | 301.10M | 272.00M |
| Net Income Ratio | -3.90% | 9.46% | 10.50% | 1.46% | 7.91% | 8.11% | 10.71% | 9.77% |
| EPS | -0.60 | 1.46 | 1.63 | 0.21 | 1.60 | 1.49 | 1.95 | 1.76 |
| EPS Diluted | -0.60 | 1.34 | 1.48 | 0.20 | 1.60 | 1.49 | 1.95 | 1.76 |
| Weighted Avg Shares Out | 166.90M | 162.90M | 161.20M | 159.60M | 136.20M | 154.60M | 154.60M | 154.60M |
| Weighted Avg Shares Out (Dil) | 166.90M | 177.60M | 177.60M | 164.10M | 136.40M | 154.60M | 154.60M | 154.60M |
Envista Schedules Fourth Quarter 2021 Earnings Call
Envista (NVST) Gets FDA 510 (k) Approval for N1 Implant System
Envista Holdings: Not Making A Dent
New Strong Sell Stocks for December 6th
New Strong Sell Stocks for November 29th
Envista Holdings Corporation (NVST) CEO Amir Aghdaei on Q3 2021 Results - Earnings Call Transcript
Envista Schedules Third Quarter 2021 Earnings Call
Envista: A Leaner And Meaner Business Post KaVo Sale
NVST or BSX: Which Is the Better Value Stock Right Now?
7 Low Price-to-Book Stocks to Buy in September
Source: https://incomestatements.info
Category: Stock Reports